Is catheter placement (36247) and percutaneous revascularization (37224, 37225, 37226, 37227) medically indicated for a patient with critical limb ischemia, diminished Ankle-Brachial Index (ABIs), high-grade stenosis in the superficial femoral artery, and a wound on the foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yes, percutaneous revascularization with catheter placement is medically indicated for this patient with critical limb ischemia.

For a 63-year-old male with critical limb ischemia (CLI), a foot wound, diminished ABIs, and high-grade superficial femoral artery stenosis, catheter placement (CPT 36247) and percutaneous revascularization (CPT 37224-37227) are strongly indicated to restore blood flow, promote wound healing, and prevent major amputation. 1, 2

Clinical Justification for Revascularization

Critical Limb Ischemia Meets Intervention Criteria

  • This patient presents with CLI manifested by a non-healing wound on the 2nd toe, which represents tissue loss (Rutherford category 5 or 6), making revascularization a Class I indication 1
  • The presence of diminished ABIs combined with tissue loss confirms hemodynamically significant disease requiring intervention 1, 2
  • Revascularization should be performed when possible in CLI patients to minimize tissue loss and preserve limb function 1, 2

Endovascular-First Approach is Appropriate

  • An endovascular-first strategy is reasonable for CLI patients, particularly given the lower procedural risk compared to open surgery 3
  • The 2017 AHA/ACC guidelines support endovascular revascularization as effective therapy for CLI with similar limb salvage rates to surgery but better survival outcomes 1
  • Percutaneous transluminal angioplasty (PTA) is specifically recommended for establishing in-line blood flow to the foot in patients with non-healing wounds 2

Anatomic Considerations

Superficial Femoral Artery Disease

  • High-grade stenosis in the superficial femoral artery represents inflow disease that must be addressed 1, 2
  • In patients with combined inflow and outflow disease with CLI, inflow lesions should be addressed first 1, 2
  • The CPT codes 37224-37227 appropriately describe percutaneous revascularization of the femoral-popliteal segment 2

Catheter Placement Justification

  • CPT 36247 describes selective catheter placement in the lower extremity arterial system, which is essential for diagnostic angiography and therapeutic intervention 2
  • Complete angiography down to the plantar arches is mandatory for proper assessment of the arterial network in CLI cases 2
  • Selective lower limb extremity angiography is essential to evaluate the arterial network and plan appropriate interventions 2

Treatment Strategy

Staged Approach if Needed

  • A staged approach to endovascular procedures is reasonable in patients with ischemic rest pain and tissue loss 2
  • If symptoms persist after inflow revascularization (SFA treatment), outflow revascularization procedures should be performed 1, 2
  • The goal is to establish in-line blood flow to the foot through at least one patent tibioperoneal artery 4

Adjunctive Techniques

  • Atherectomy can be used for plaque removal in the SFA to improve luminal gain if needed 2, 5
  • Stenting may be appropriate if there is significant residual stenosis, flow-limiting dissection, or elastic recoil after angioplasty 2

Expected Outcomes and Post-Procedural Care

Limb Salvage Benefits

  • Complete revascularization achieving in-line flow to the foot is associated with major amputation-free survival rates of 97% at 3 years 4
  • Endovascular therapy in CLI patients results in visible healing of ulcerated tissue and avoidance of amputation in 82-92% of cases 5
  • Mean postoperative ABI improvement from 0.53 to 0.87 has been demonstrated with successful revascularization 4

Mandatory Post-Procedure Management

  • Antiplatelet therapy must be administered after endovascular procedures to improve patency and reduce amputation rates 2
  • Regular follow-up with duplex ultrasound is required to monitor patency and detect restenosis early 2
  • An interdisciplinary care team approach is recommended for comprehensive wound care and monitoring 2

Critical Pitfalls to Avoid

Monitoring Requirements

  • The patient requires monitoring for compartment syndrome after revascularization, particularly given the chronicity of symptoms 1, 6
  • Watch for reperfusion complications including hyperkalemia, systemic inflammatory response, and cardiovascular collapse 6
  • Restenosis remains a significant concern after endovascular interventions and requires surveillance 2

Contraindications to Consider

  • Ensure there are no contraindications to anticoagulation, as systemic heparin should be administered during the procedure 1
  • Verify the limb is salvageable (not Category III acute limb ischemia with insensate/immobile foot) 1

Technical Considerations

  • Risk of distal embolization during intervention must be considered, especially if heavily calcified lesions are present 2
  • Vessel perforation or rupture can occur and requires immediate recognition 2

Medical Necessity Summary

This patient meets all criteria for medically necessary percutaneous revascularization: CLI with tissue loss (wound), hemodynamically significant disease (diminished ABIs and high-grade SFA stenosis), and anatomically suitable lesions for endovascular treatment. 1, 2 The requested CPT codes 36247 and 37224-37227 accurately describe the necessary diagnostic angiography and therapeutic revascularization procedures to restore blood flow, promote wound healing, and prevent major amputation in this high-risk clinical scenario.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Lower Extremity Peripheral Arterial Disease with Endovascular Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Critical Limb Ischemia.

Circulation. Cardiovascular interventions, 2016

Research

Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists, 2006

Guideline

Medical Necessity Determination for Percutaneous Mechanical Thrombectomy and Iliac Stenting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.